Procyon Advisors LLC decreased its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB – Get Rating) by 3.8% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 2,503 shares of the financial services provider’s stock after selling 100 shares during the quarter. Procyon Advisors LLC’s holdings in iShares Biotechnology ETF were worth $329,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently modified their holdings of the business. Private Trust Co. NA boosted its holdings in shares of iShares Biotechnology ETF by 1.5% in the fourth quarter. Private Trust Co. NA now owns 5,565 shares of the financial services provider’s stock valued at $731,000 after purchasing an additional 80 shares during the period. Apollon Wealth Management LLC boosted its holdings in shares of iShares Biotechnology ETF by 0.8% in the third quarter. Apollon Wealth Management LLC now owns 10,445 shares of the financial services provider’s stock valued at $1,222,000 after purchasing an additional 83 shares during the period. Hudock Inc. boosted its holdings in shares of iShares Biotechnology ETF by 0.9% in the third quarter. Hudock Inc. now owns 9,623 shares of the financial services provider’s stock valued at $1,125,000 after purchasing an additional 84 shares during the period. Personal Capital Advisors Corp boosted its holdings in shares of iShares Biotechnology ETF by 3.2% in the third quarter. Personal Capital Advisors Corp now owns 2,877 shares of the financial services provider’s stock valued at $336,000 after purchasing an additional 88 shares during the period. Finally, Patriot Financial Group Insurance Agency LLC boosted its holdings in shares of iShares Biotechnology ETF by 1.5% in the third quarter. Patriot Financial Group Insurance Agency LLC now owns 5,868 shares of the financial services provider’s stock valued at $686,000 after purchasing an additional 89 shares during the period. Institutional investors own 58.02% of the company’s stock.
iShares Biotechnology ETF Trading Up 0.0 %
Shares of NASDAQ IBB opened at $126.06 on Wednesday. The stock has a 50 day moving average price of $130.67 and a 200 day moving average price of $129.13. iShares Biotechnology ETF has a 52-week low of $104.29 and a 52-week high of $138.74.
iShares Biotechnology ETF Company Profile
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.
Featured Articles
- Get a free copy of the StockNews.com research report on iShares Biotechnology ETF (IBB)
- After an Earnings Blowout, Is Ciena Stock a Buying Opportunity?
- Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
- Meta Breaks Out Of A Base, Looks Like A Growth Stock Again
- The Bottom Is In For McCormick & Company
- Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.
